Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 316, pseudogene (RN7SL316P)

Target
RN7SL316P
Molecular classification
Other (non-coding RNA pseudogene)
01

Overview

RN7SL316P (RNA, 7SL, cytoplasmic 316, pseudogene) is a human pseudogene corresponding to a non-coding RNA of the 7SL RNA family. The 7SL RNA is a key RNA component of the signal recognition particle (SRP), which plays a central role in targeting proteins to membranes. However, RN7SL316P is a pseudogene — a genomic segment with sequence similarity to functional 7SL RNA genes but lacking the ability to produce a functional RNA or protein product. Such 7SL-derived pseudogenes arise from the reverse transcription and reintegration of 7SL RNA sequences into the genome, and are typically transcriptionally inactive and nonfunctional. While some pseudogenes can have regulatory functions, RN7SL316P is not classified as a therapeutic target, has no known biological function, is not associated with disease, and has no known drug interactions. Key points: - RN7SL316P is a nonfunctional pseudogene, not a receptor, enzyme, transporter, or therapeutic target. - It is simply a sequence remnant related to the functional 7SL RNA gene, with no established role in cellular biology or disease. - There are hundreds of similar 7SL pseudogenes in the human genome, most of which are truncated or mutated copies without detectable biological activity. Note on correctness: This entry is not a bona fide therapeutic target and is a nonfunctional pseudogene — its inclusion as a "target" is incorrect. The name is not misspelled, but the entity itself is irrelevant to therapeutic targeting.

Other names
RN7SL316P7SL RNA pseudogene 316RNA, 7SL, cytoplasmic 316, pseudogene
02

Mechanism of action

None

03

Biological functions

None (no known function; non-coding and presumed nonfunctional)
04

Disease associations

None (not reported to be involved in disease; lacks known functional role)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 316, pseudogene (RN7SL316P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 316, pseudogene (RN7SL316P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call